## Gene Summary
CXCL5, also known as C-X-C motif chemokine ligand 5, belongs to the CXC chemokine family which are critical mediators of immune cell attraction and function. CXCL5 primarily recruits neutrophils to sites of inflammation and has a role in the immune response and regulation. The protein encoded by this gene plays a part in inflammatory processes and its expression is often induced by inflammatory mediators such as interleukin-1 or tumor necrosis factor-alpha.

## Gene Drugs, Diseases, Phenotypes, and Pathways
CXCL5 is significantly involved in pathologies characterized by neutrophilic infiltration, such as chronic obstructive pulmonary disease (COPD), asthma, and various inflammatory or autoimmune diseases. Studies have implicated CXCL5 in various cancers, including colorectal and lung cancers, suggesting a role in tumor progression and metastasis. The chemokine and its receptors are involved in multiple signaling pathways including those linked to the inflammatory response and cancer development. Notably, CXCL5 signaling through its receptor CXCR2 has been explored as a potential therapeutic target in inflammatory and cancerous diseases.

## Pharmacogenetics
The pharmacogenetic implications of CXCL5 primarily revolve around its influence on inflammation and cancer progression, rather than direct associations with specific drugs. However, drugs targeting the CXCL5-CXCR2 axis may be influenced by genetic variations in CXCL5. For instance, inhibitors of CXCR2, which could potentially modify the activity of CXCL5, may have varied efficacies depending on the individual genetic expression and regulation of CXCL5. This suggests a pharmacogenetic relevance, particularly in the context of personalized treatments for inflammatory and oncological conditions where CXCL5 plays a contributory role. Research in this area is emergent, indicating future possibilities for more defined pharmacogenetic profiles related to CXCL5.